Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Organisation › Details

ObsEva (Group)

ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA. ObsEva's founding assets are innovative products at early stages of clinical development addressing preterm labor. *

 

Period Start 2012-01-01 established
  Today ObsEva S.A. (Nasdaq: OBSV)
Products Industry nolasiban (OBE001)
  Industry 2 reproductive health
Persons Person Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono)
  Person 2 Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc)
     
Region Region Plan-les-Ouates GE
  Country Switzerland
  Street 12 Chemin des Aulx
  City 1228 Plan-les-Ouates GE
  Tel +41-22-552-3840
    Address record changed: 2017-01-28
     
Basic data Employees n. a.
     
    * Document for �About Section�: ObsEva S.A.. (8/29/13). "Press Release: ObsEva SA Announces CHF 32 Million Series A Funding from Leading Venture Capital Firms and a License Agreement with Merck Serono". Geneva.
     
   
Record changed: 2018-04-15

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for ObsEva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top